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RESEARCH ARTICLE
Cancer patients’ experiences with and
opinions on the process ’Screening of Distress
and Referral Need’ (SDRN) in clinical practice:
A quantitative observational clinical study
Floor M. van Nuenen1, Stacey M. Donofrio2, Harry B. M. van de Wiel1, Josette E. H.
M. Hoekstra-Weebers1,3*
1 Wenckebach Institute, University Medical Center Groningen, University of Groningen, Groningen, the
Netherlands, 2 Department of Psychology, University of Groningen, Department of Psychology, Groningen,




This observational clinical study investigated patients’ experiences with and opinions on the
Dutch ‘Screening of Distress and Referral Need’ (SDRN) process implemented in oncology
practice. Insight into these can guide improvement of the SDRN process.
Methods
Patients from hospitals that had implemented SDRN for at least a year completed questions
on experiences with essential SDRN process steps (1: completion of the Distress Thermom-
eter and Problem List as screening instrument (DT&PL), 2: information on SDRN+DT&PL,
3: information on referral options, 4: discussing DT&PL responses, 5: referral when
needed), and on opinions about SDRN and DT&PL. Descriptive and univariate analyses
were conducted.
Results
Of the 498 participants (response = 54%), 81% completed a DT&PL, of whom 86–87%
was exposed to steps 2–3 and 76% discussed responses; only three needing care were
not offered referral. Sixty-one percent encountered all SDRN steps and 78% would rec-
ommend SDRN to others. Recommending SDRN is related to more frequent DT&PL com-
pletion (t = -2.5; p0.01), receipt of information on SDRN+DT&PL and referral options (X2
= 4.9; p0.05 and X2 = 5.9; p0.05 respectively), discussion of responses (X2 = 10.2;
p0.001), and fuller exposure to SDRN process steps (X2 = 14.8; p0.01). Percentages
(strongly) agreeing were highest on the DT&PL being useful (90%) and suitable (88%),
and lowest on burdensome (31%) and time-consuming (28%).
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Conclusion
The majority of participating patients encountered the steps of the SDRN process consid-
ered essential, with 3/5 having encountered all steps. Referral is largely targeted to patients’
need. Patients’ perceived benefit of SDRN increases with fuller exposure to all process
steps. Therefore, improvements, particularly in DT&PL completion and discussion of
responses should be made.
Introduction
Distress screening was developed to decrease the discrepancy between the percentage of cancer
patients experiencing clinically-elevated distress for which professional psychosocial care is war-
ranted (percentages reported range between 25–50% [1,2]) and the percentage of patients actu-
ally receiving such care (percentages reported vary between 7–24% [3,4]). Regular screening of
level and nature of distress during cancer treatment and follow-up may facilitate appropriate
and timely referral to psychosocial and/or allied healthcare professionals, and thus ensure that
patients needing additional care receive such care before distress becomes overwhelming.
Randomized controlled trials (RCTs) mostly focus on the effect of a distress screening pro-
cess on patient-reported outcomes such as quality of life, patient-doctor communication, or
on outcomes such as referrals or medical consumption. Results reported are inconsistent and
vary from a positive to no effect [5–13]. Studies examining a more extensive process including
triage more often found positive results [5,6,8,9], in contrast to studies investigating a process
consisting of giving completed patient-reported outcome measures to a healthcare provider
who decided independently what to do with the results [7,10–13]. This suggests that triage
should be part of a distress screening procedure. It remains unclear from the studies using tri-
age whether communication about responses on a screening instrument took place at all, only
with patients who scored above a cutoff, or with all patients.
The literature on patients’ opinions on a distress screening procedure or on the instrument
used is sparse, although patients are supposed to benefit from distress screening. According to
three (randomized) controlled trials, between 87–99% of patients thought that a screening pro-
cedure would have added value in oncologic practice [14–16]. Four studies conducted in a
routine clinical setting reported that 49–98% of patients replied that the instrument used for
screening was useful [17–20]. Only one study examined patients’ opinions on the Distress
Thermometer (DT) in combination with the Problem List (PL) [20], although this instrument
is often used for screening worldwide.
In the Netherlands, a process ‘Screening for Distress and Referral Need’ (SDRN) was devel-
oped including the following steps: 1) regular completion of the Dutch DT&PL [21] during
curative or palliative treatment and follow-up, 2) discussion of the responses between care pro-
vider and patient, regardless of whether the DT-score is below or above the cut-off, and 3)
referral if needed or wished by the patient to a psychosocial and/or allied healthcare provider
depending on the nature of the problems experienced [22,23]. Additionally, we considered
providing 4) information to patients about the goal of SDRN and the DT&PL and 5) about
referral options and the specific expertise of psychosocial and allied healthcare professionals to
be essential. SDRN has been implemented in routine clinical practice in the majority of the
hospitals in the north and east of the Netherlands for at least one group of patients, mostly
breast cancer patients. Health care providers of these hospitals find the implementation of this
process feasible [24]. However, the extent to which patients experience the different steps in
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this process in daily oncology practice is unknown and information on patients’ opinions on a
screening process is very limited. It may well be that patients who are exposed to relevant steps
in an SDRN process have a more positive opinion of the instrument used and perceive the pro-
cess as more relevant to the quality of the care they receive.
Therefore, this observational clinical study examines: 1) patients’ experiences with the
above-mentioned essential steps of the Dutch SDRN process in clinical practice; 2) patients’
opinions on SDRN and on the DT&PL as screening instrument; 3) and relationships between
patients’ experiences and opinions.
Materials and methods
Patients
Oncology patients visiting a surgical, medical, gynaecological or urological outpatient depart-
ment from ten Dutch hospitals that had implemented the SDRN process in routine clinical
practice for at least one year, who were aware of their treatment plan, cognitively and physi-
cally able to complete a questionnaire,18 of age, and sufficiently fluent in Dutch were eligible
for study participation. Hospitals were located in the northeastern part of the Netherlands, the
catchment area of the Netherlands Comprehensive Cancer Organization, location Groningen
(IKNL-G). IKNL-G supported SDRN implementation in these hospitals and provided central-
ized project management [24]. Patients from the first 10 of the 21 hospitals in the IKNL-G area
that completed SDRN implementation for at least one group of patients for at least a year were
invited to participate in the study. Three hospitals had implemented SDRN for breast cancer
patients only. One hospital had implemented SDRN for prostate and breast cancer patients.
The remaining hospitals had implemented SDRN for patients with breast, digestive, prostate
and/or other types of cancer.
Procedure
The medical specialist or nurse informed all eligible patients visiting an outpatient clinic about
the study and invited them to participate. Eligible patients were informed that SDRN had been
implemented and that we invited them in a study assessing their experiences with SDRN in
the hospital. Patients received a package including written information about the study, the
questionnaire, an informed consent form and a pre-franked return envelope in which they
could return the completed questionnaire to the IKNL-G. In eight hospitals 100 packages were
handed out, in one hospital 50 and in the last 66, because the number of new cancer patients in
the last two hospitals was lower (Dutch Cancer Registry). Handing out of packages took 2–4
weeks. IKNL-G coordinated the study. No information was given by the hospitals about the
patients approached for participation for reasons of anonymity. Consequently, non-respond-
ers were not mailed or phoned to remind them to send a completed questionnaire to IKNL-G.
The medical ethical committee of the University Medical Centre Groningen exempted the
study from full review; no formal approval was needed according to the Dutch Medical
Research Involving Human Subjects Act. The study was performed according to the Helsinki
Declaration and the ethics committees of the participating hospitals.
Instrument
Patients were asked whether they completed a DT&PL since their diagnosis. Those who
answered ‘yes’ responded to a further seven self-developed questions assessing their experi-
ences with SDRN (questions 1–5), and their opinions on the DT&PL (question 6) and
SDRN (question 7). Patients were asked to indicate: 1) how often they completed a DT&PL;
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2) if they received information about the purpose of SDRN and the DT&PL; 3) if they
received information about referral options and the expertise of different healthcare provid-
ers; 4) if they discussed responses with a care provider, and if yes, with whom and their sat-
isfaction with the discussion; 5) if they were offered referral according to their need; 6) their
agreement on eleven statements about the DT&PL; and 7) if they would recommend SDRN
to other cancer patients as a proxy of their general opinion of SDRN as a process (questions
and response options in S1 File).
Additionally, patients completed questions on the following socio-demographic and ill-
ness-related characteristics; age, gender, education level (low (elementary or low vocational
school), middle (secondary or middle vocational education), high (high vocational or univer-
sity)), cancer type, date of diagnosis, treatment modalities, and treatment phase (watchful wait-
ing, receiving active treatment, follow-up). A medical specialist placed patients in a curative
and palliative treatment group based on their cancer type and treatment.
Analyses
Descriptive analyses were computed to examine patients’ answers to the questions. Indepen-
dent t-tests (continuous variables) and chi-square tests (categorical variables) were performed
to investigate differences between respondents who completed a DT&PL since their cancer
diagnosis and those who did not. We conducted independent samples t-tests, Mann-Whitney
U-tests and Spearman’s rho correlations (continuous variables), and chi-square and Fisher
exact tests (categorical variables) to examine univariate relationships between variables. Treat-
ment modalities were dichotomized into non-intensive treatment (watchful waiting, surgery
only, and radiotherapy only) and intensive treatment (the remaining modalities) for analysis
because of the low numbers in some of the categories. All tests were two-sided. We used SPSS,
version 22, for analyses.
Results
Of the 916 questionnaires distributed, 498 were returned (response = 54%). Response was
comparable between hospitals. Table 1 shows information on respondents’ socio-demographic
and illness-related characteristics. Of the respondents, 78% were women and 24% had com-
pleted low level education. Mean age was 59.8 years. Sixty-seven percent had breast cancer and
mean time since diagnosis was 1.2 years. Respondents received different types of treatment, of
whom 78% intensive treatment, 92% received treatment with a curative intent, and 46% was
under active treatment.
No information was provided by the physician or nurse about patients approached for
study participation to the researchers. Consequently, participants could not be compared to
non-participants.
Regarding the first SDRN step, 81% (N = 398) of the patients answered that they had com-
pleted a DT&PL in clinical practice and 19% (N = 94) (6 missing) that they had not done so.
Comparison of those who did and those who did not complete a DT&PL showed significant
differences in gender, cancer diagnosis and time since diagnosis (Table 1). The percentages of
men and of prostate cancer patients were lower and time since diagnosis was shorter in the
group that completed a DT&PL. Twenty-eight of the 77 (36%) men who completed a DT&PL
had prostate cancer versus 19 of the 32 (59%) men who did not complete a DT&PL. Excluding
the prostate cancer patients from analysis, no gender difference was found between those who
completed a DT&PL and those who did not (X2 = 0.9, p = 0.4).
The following results relate to the 398 respondents who completed a DT&PL since
diagnosis.
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Mean ± SD 59.8±10.8 59.4±10.8 61.2±10.237. t = 1.4ns
Range 29.9–87.5 29.9–87.5 1–85.1
Gender (N(%))
Men 111(22) 77(19) 32(34) X2 = 9.5
Women 387(78) 321(81) 62(66)
Education (N(%))
Low 116(24) 96(25) 17(19) X2 = 1.6ns
Middle 232(48) 185(47) 46(50)
High 139(29) 109(28) 29(32)
Type of cancer (N(%))
Breast 333(67) 272(68) 57(61) X2 = 15.5
Prostate 48(10) 28(7) 19(20)
Digestive 32(6) 27(7) 5(5)
Other 85(17) 71(18)† 13(14)††
Time since diagnosis in years
Mean ± SD 1.2±1.9 1.1±1.7 1.7±2.5 t = 2.5
Range 0.0–19.4 0.0–18.9 0.0–19.4
Treatment modality (N(%))
Watchful waiting 9(2) 8(2) 1(1) X2 = 11.8ns
Surgery 80(16) 65(17) 14(15)
Surgery + radiotherapy 98(20) 71(18) 25(27)
Surgery + chemotherapy 82(17) 65(17) 15(16)
Surgery + radiotherapy + chemotherapy 138(28) 119(30) 19(20)
Surgery + immunotherapy and/or hormonal
therapy
20(4) 17(4) 3(3)
Radiotherapy 18(4) 10(3) 7(8)
Chemotherapy 30(6) 24(6) 6(7)
Radiotherapy + chemotherapy 19(4) 16(4) 3(3)
Treatment intensity (N(%))
Non-intensive 107(22) 83(21) 22(24) X2 = 0.3ns
Intensive 387(78) 312(79) 71(76)
Treatment intent (N(%))
Curative 452(92) 360(91) 86(93) X2 = 0.2ns
Palliative 42(9) 35(9) 7(8)
Treatment phase (N(%))
Watchful waiting 9(2) 8(2) 1(1) X2 = 2.8ns
Under active treatment 227(46) 188(48) 37(40)
Follow-up 253(52) 194(50) 55(59)
§ N varied somewhat due to missing data
† = 22 hematologic, 18 lung, 14 gynaecologic, 6 sarcoma/bone, 5 skin, 3 liver, 1 urologic, 2 unspecified;
†† = 2 hematologic, 1 lung, 1 gynaecologic, 2 sarcoma/bone, 4 skin, 2 head/neck, 1 brain;
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Patients’ experiences with SDRN (Table 2)
Of these 398 respondents, 36% completed the DT&PL once, 35% twice, 20% three times, and
9% between four and eight times. Eighty-six percent received information on the purpose of
SDRN and the DT&PL, and 87% received information about referral options and the expertise
of psychosocial and allied healthcare professionals.
DT&PL responses were discussed with 76% of the respondents. Of these, 93% indicated
that the nurse discussed responses with them, and 95% was (very) satisfied with this
discussion.
Fifty-four respondents (19%) indicated that they needed care, of whom only three patients
(6% (1% of total group)) were not offered a referral. Of the 289 respondents who completed
the referral question, eight (3%) answered that the DT&PL was not discussed with them (2
missing), while of the 109 respondents who did not answer it, 90% indicated that responses
were not discussed (X2 = 292.6; p0.001).
Patients opinions on SDRN and the DT&PL
Of the respondents who completed a DT&PL in the clinic, 78% would recommend SDRN to
other cancer patients, while 22% would not (38 missing) (Table 2).
Regarding the first eight statements on the DT&PL, the strongest agreement was found
with the DT&PL being: ‘suitable for its purpose’ and ‘useful for my care provider’. The stron-
gest disagreement was found with the statement that DT&PL completion is ‘time-consuming’.
Concerning the three statements on patients’ perceptions on the purpose of DT&PL comple-
tion, the strongest agreement was found with the statement that it ‘offers insight into the prob-
lems I experience’ (Table 3).
Relationships between patients’ experiences and their opinions
Regarding SDRN. Those who would recommend SDRN had completed a DT&PL signifi-
cantly more often than those who would not recommend SDRN. A significantly higher percent-
age of those who would recommend SDRN had received information about the purpose of
SDRN and the DT&PL, and about referral options and the expertise of different healthcare dis-
ciplines, had discussed responses with a care provider, and they were significantly more satisfied
with the discussion of the responses than those who would not recommend SDRN. Referral
according to need did not significantly affect SDRN recommendation (Table 2). Because of the
low numbers in two cells an additional comparison was performed between those needing care
and those not needing care. No differences were found between these two groups.
A significantly higher percentage of patients who would recommend SDRN to others was
exposed to the full SDRN process (Table 2).
Regarding DT&PL. Mann-Whitney tests showed five differences between respondents
who received information about SDRN and the DT&PL and those who did not, namely the
first group perceived completing the DT&PL as significantly more ‘pleasant’, and less ‘difficult’
and ‘time-consuming’ than patients who did not receive information. Additionally, the first
group agreed significantly more that completing the DT&PL ‘offers insight into the problems
they experience’ and that it ‘helps in the communication with their care provider’. Significant
differences were found on six of the 11 DT&PL statements between patients who discussed
responses with their care provider and those who did not. Satisfaction with the discussion cor-
related significantly, but weakly, with nine DT&PL statements. Respondents who would rec-
ommend SDRN to others were significantly more positive on ten of the 11 DT&PL statements
(Table 3).
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Table 2. Descriptives on study questions 1–5 and on variable created post-hoc, and univariate effects on respondents’ recommendation (question 7).
7) Recommend others? N(%) Univariate test










Between four and eight times 34(9)
Missing 28
Mean±SD 2.1±1.1 2.2±1.1 1.8±0.8 t = -2.5
2) Received information on (purpose of) SDRN and DT&PL?
Yes 332(86) 245(89) 64(80) X2 = 4.9
No 53(14) 16(20)
Missing 13 29(11)
3) Received information about referral options and expertise?
Yes 334(87) 247(89) 63(79) X2 = 5.9
No 50(13) 17(21)
Missing 14 30(11)
4) Response pattern discussed?
Yes 289(76) 223(80) 50(64) X2 = 10.2
No 94(24) 29(36)
Missing 15 54(20)
4a) If yes, with whom
Nurse 272(95)
Medical specialist 6(2)
Another healthcare provider 7(3)
Missing 4
4b) If yes, satisfaction with discussion
Very satisfied (1) 89(32)
Satisfied (2) 178(63)
Moderately satisfied (3) 13(5)
Dissatisfied (4) 1(0.4)
Missing 8
Mean±SD 1.7±0.6 1.7±0.5 2.0±0.7 t = 3.4
5) Referral according to need?
Offered but not needed 164(57) 125(56) 28(54) Fisher’s exact = 5.0ns
Not offered and not needed 71(25) 15(29)
Offered and needed 51(18) 53(24) 7(14)
Not offered but needed 3(1) 43(19) 2(4)
Missing 109 1(1)
Extent of exposure to SDRN
1) DT&PL only 18(5) 6(2) 4(5) X2 = 14.8
2) DT&PL+info SDRN/DT&PL or info referral options/expertise 40(10) 23(8) 10(13)
3) DT&PL+info SDRN/DT&PL and info referral options/expertise 51(13) 28(10) 16(20)
4) DT&PL+info SDRN/DT&PL or info referral+discussion 48(12) 30(11) 13(16)
5) DT&PL+info SDRN/DT&PL+info referral+discussion 241(61) 193(69) 37(46)





% do not always add up to 100 due to rounding
https://doi.org/10.1371/journal.pone.0198722.t002
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Discussion
The present quantitative observational clinical study explored patients’ experiences with the
different essential steps of the Dutch Screening for Distress and Referral Need process imple-
mented long-term in everyday oncology practice. Additionally, their opinions on this process
and the DT&PL were examined. Overall, a majority of participating patients encountered one
or more of the steps considered essential in the Dutch SDRN process and, with the exception
of three patients, referral was according to need. Patients exposed to essential SDRN procedure
steps are more positive on SDRN and the DT&PL. Fuller exposure is related with higher posi-
tivity; patients who experienced more of the SDRN process are more likely to recommend it to
others.
Regarding patients’ experience with the first step in the SDRN process, we found that more
than four-fifths of the respondents had completed a DT&PL since they were diagnosed with
cancer. Given that SDRN had been implemented for at least a year in participating hospitals,
the percentage of patients who completed a DT&PL was lower than we expected. Compared to
three recent studies, reporting percentages varying between 40–73% [25–27], our finding is
high, but it is lower than that reported in a fourth study (94%) [28]. Similarly to our study,
three of these studies examined the situation in oncology practice after a systematic implemen-
tation process [26–28]. We found that some patients did not complete the DT&PL. It may be
that the instrument was not well introduced for certain patient groups; patients may not have
been asked to complete a DT&PL, possibly because of shortage of time [24]. We found that
Table 3. Descriptives on the DT&PL opinion statements (question 6), and univariate effects of opinions on information received, responses discussed, satisfaction
with discussion, and recommending others.






























Is pleasant 88(30) 135
(46)
47(16) 26(9) 102 3.4 3.3 0.28 6.8
Is easy 132(44) 106
(35)
44(15) 20(7) 96 1.2 1.3 0.14 4.7
Is burdensome 15(5) 74(26) 64(22) 136(47) 109 -1.9 -1.0 -0.23 -3.8
Is useful for myself 99(33) 107
(36)
54(18) 38(13) 100 0.6 3.7 0.19 7.4
Is difficult 28(10) 58(20) 67(23) 142(48) 103 -2.6 -0.4 -0.09 -1.5
Is time-consuming 24(8) 58(20) 60(21) 147(51) 109 -3.9 -2.1 -0.1 -4.3
Is suitable for its
purpose
184(59) 91(29) 22(7) 15(5) 86 0.7 0.7 0.21 6.8




13(4) 19(6) 83 1.4 1.7 0.23 6.2










63(19) 70(21) 67 2.2 4.5 0.24 7.4








% does not always add up to 100 due to rounding off
https://doi.org/10.1371/journal.pone.0198722.t003
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fewer prostate cancer patients and those diagnosed longer ago did so compared to others, pos-
sibly because they were not asked to complete it, or they did not feel it necessary because they
experienced little distress or less need for additional professional care [1,24,29,30]. Future
research could examine patients’ and care providers’ barriers to instrument completion in
oncology practice. Interestingly, patients who completed a DT&PL more often were more
likely to recommend SDRN to others. This may suggest that patients increasingly understand
the benefit of SDRN.
As for the provision of information, the vast majority of patients who completed a DT&PL
indicated they received information about the purpose of SDRN and the DT&PL, and about
referral options and the professional expertise of those they could be referred to (86% and 87%
respectively). Adequate provision of information may increase patients understanding and
motivation for adopting appropriate health interventions, such as SDRN. The relevance of pro-
viding information is reflected in the findings that opinions on SDRN and on the DT&PL
were more positive in patients who received information on SDRN and the DT&PL and on
availability and expertise of allied/psychosocial care providers.
Concerning patients’ experience with the fourth SDRN process step, namely communica-
tion, we found that DT&PL responses were discussed with three of four patients. This was
lower than expected given that communication, regardless of the extent of distress, is an essen-
tial step in the Dutch SDRN process [22]. Possible explanations for this finding may be that
care providers perceived a lack of time or skills [24,27,31]. Remarkably, 95% of the patients
with whom responses were discussed were very satisfied and discussion of responses was most
strongly related to recommending SDRN to others. These findings may encourage nurses to
discuss responses.
Adequate referral is the fifth essential step in the SDRN process. This study suggests that
once SDRN is implemented, it is patient need that dictates referral. Promisingly, only three of
those indicating a need for care were not offered a referral; a major aim of distress screening is
to ensure that cancer patients needing care are referred. Unfortunately, 25% of the respondents
did not indicate whether referral was offered according to need. Of those who did not answer
that question, 90% responded that the DT&PL was not discussed with them, while with 97% of
those who did answer, responses were discussed. Thus, discussing responses seems instrumen-
tal in correctly identifying patients in need of additional care. This was also mentioned by the
healthcare providers [24].
One-fifth of patients indicated a need for additional care at the time responses were dis-
cussed. This is comparable to some studies but lower than reported in other studies [32–35].
This range could be explained by the wording of the question. Studies with higher percentages
ask about need in general terms [34,35], while those with lower percentages inquire more spe-
cifically about time or type of care [32,33].
All in all, patients’ evaluation of the DT&PL as a tool in the SDRN process is largely positive,
though some patients were somewhat critical. This is comparable with studies investigating
other instruments [17–19], and in line with care providers’ opinion on the DT&PL [24]. Nota-
bly, opinions on the DT&PL were also more positive in patients with whom responses were
discussed, who were more satisfied with the discussion, and who would recommend SDRN to
others. This suggests that incorporating the DT&PL in the SDRN process in a meaningful and
clear manner, so that patients feel that instrument completion matters, has a positive effect.
In total, 78% of the respondents who completed a DT&PL would advise others to partici-
pate in SDRN. This percentage is somewhat lower than percentages found in (randomized)
controlled intervention studies [14–16], but in RCTs much attention is given to ensure that
the process is executed according to protocol for the duration of the trial. Our study reflects
the less controllable situation in real world practice.
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Overall, 61% of patients who completed a DT&PL encountered all steps in the process as
recommended. We also found that patients are more positive about SDRN the more frequently
they completed a DT&PL and the more all steps are followed. In fact, the likelihood of recom-
mending SDRN to other patients increases with fuller exposure to the process. This finding
underlines that care providers should adhere to all SDRN process steps, particularly to discuss-
ing DT&PL responses with all patients.
This study has a few limitations. The response rate was 54%, which is comparable to mailed
questionnaire studies [36]. Due to study design, we cannot compare patients who participated
to those who did not. Consequently, we cannot be certain that responders are not a selection
of the total population approached. Representativeness and generalizability may be affected.
Conclusions are based on the responses of the participating patients. Some of the hospitals
implemented SDRN only for breast cancer patients; this is why breast cancer patients are over-
represented in the study. However, the sample is broad, including patients from various
departments in 10 different hospitals, with wide variation on demographic and illness-related
variables. The cross-sectional design, without control group, means that we cannot state con-
clusively that the SDRN process is the reason only 3 patients were not referred despite need.
Regretfully, 20% of participants did not complete a DT&PL and thus could not answer all
questions. This underlines the need for continuing attention to fully implementing SDRN.
Also, it is unfortunate that patients who did not complete the DT&PL or with whom responses
were not discussed were not asked about the reasons for this not happening.
Conclusions
This study shows that, according to participating patients’ experiences a year after implemen-
tation, the majority encountered the steps of the SDRN process considered essential, with 3/5
having encountered all steps. Patients’ views on the DT&PL as tool are mainly positive.
Patients’ perceived benefit of SDRN increases with fuller exposure to all steps, especially the
discussion. After implementation, referrals are largely targeted to participating patients’ needs.
Improvements in the execution of the SDRN process can be made, particularly in ensuring
that all patients are regularly offered to complete a DT&PL and that responses are discussed
with all patients.
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